Expression of cyclin a, B1 and D1 after induction of cell cycle arrest in the Jurkat cell line exposed to doxorubicin

Cell Biology International

Volumn 36, Issue 12, 2012, Pages 1129-1135

  Zuryn, Agnieszká ^a   Litwiniec, Anna ^b   Gackowska, Lidia ^a   Pawlik, Andrzej ^a   Grzanka, Aleksandra Antonina ^a   Grzanka, Alina ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b PLANT BREEDING AND ACCLIMATIZATION INSTITUTE NATIONAL RESEARCH INSTITUTE   (Poland)

Author keywords

Cell cycle arrest; Cyclin; Doxorubicin; G2 M; Jurkat

Indexed keywords

CYCLIN A; CYCLIN B1; CYCLIN D1; DOXORUBICIN; LIPOCORTIN 5;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL DEATH; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKEMIA CELL LINE; M PHASE CELL CYCLE CHECKPOINT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84871980747     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20120274     Document Type: Article

References (36)

1. Acin S, Li Z, Mejia O, Roop DR, El-Naggar AK, Caulin C. Gain-of-function mutant p53 but not p53 deletion promotes head and neck cancer progression in response to oncogenic K-ras. J Pathol 2011;225:479-89.
2. Aytac U, Sato K, Yamochi T, Ohnuma K, Mills GB, Morimoto C et al. Effect of CD26/dipeptidil peptidase IV on Jurkat sensitivity to G2/M arrest induced by topoisomerase II inhibitors. Br J Cancer 2003;88:455-62.
3. Bedi A, Barber JP, Bedi GC, el-Deiry WS, Sidransky D, Vala MS et al. BCR-ABL-mediated inhibition of apoptosis with delay of G2/M transition after DNA damage: a mechanism of resistance to multiple anticancer agents. Blood 1995;86:1148-58.
4. CalbóJ, Parreň o M, Sotillo E, Yong T, Mazo A, Garriga J et al. G1 cyclin/ cyclin-dependent kinase-coordinated phosphorylation of endogenous pocket proteins differentially regulates their interactions with E2F4 and E2F1 and gene expression. J Biol Chem 2002;277:50263-74.
5. Castedo M, Perfettini JL, Roumier T, Kroemer G. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 2002;9:1287-93.
6. Castedo M, Perfettini JL, Roumier T, Yakushijn K, Horne D, Medema R et al. The cell cycle checkpoint kinase Chk2 is a negative regulator of mitotic catastrophe. Oncogene 2004;23:4353-61.
7. Cheng J, Haas M. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol Cell Biol 1990;10:5502-9.
8. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F. Cytometry of cyclin proteins. Cytometry 1996;25:1-13.
9. Ehrhardt H, Schrembs D, Moritz C, Wachter F, Haldar S, Graubner U et al. Optimized anti-tumor effects of anthracyclines plus vinca alkaloids using a novel, mechanism-based application schedule. Blood 2011;118:6123-31.
10. Gertsch J, Güttinger M, Sticher O, Heilmann J. Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds. Pharm Res 2002;19:1236-43.
11. Gladden AB, Woolery R, Aggarwal P, Wasik MA, Diehl JA. Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma. Oncogene 2006;25:998-1007.
12. Grzanka A, Zuryń A, Styczyński J, Grzanka AA, Wisniewska H. The effect of doxorubicin on the expression of cyclin A in K-562 leukemia cell line. Neoplasma 2005;52:489-93.
13. Halloway SL, Glotzer M, King RW, Murray AW. Anaphase is initiated by proteolysis rather than by the inactivation of maturation-promoting factor. Cell 1993;73:1393-402.
14. Heald R, McLoughlin M, McKeon F. Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated Cdc2 kinase. Cell 1993;74:463-74.
15. Innocente SA, Abrahamson JL, Cogswell JP, Lee JM. P53 regulates a G2 checkpoint through cyclin B1. Proc Natl Acad Sci USA 1999;96:2147-52.
16. Jackson JG, Pereira-Smith OM. Primary and compensatory roles for RB family members at cell cycle gene promoters that are deacetylated and downregulated in doxorubicin-senescence of breast cancer cells. Moll Cell Biol 2006;26:2501-10.
17. Karpinich NO, Tafani M, Schneider T, Russo MA, Farber JL. The course of etoposide-induced apoptosis in Jurkat cells lacking p53 and Bax. J Cell Physiol 2006;208:55-63.
18. Ling YH, el-Naggar AK, Priebe W, Perez-Soler R. Cell cyle-dependent cytotoxicity, G2/M phase arrest, and disruption of p34cdc2/cyclin B1 activity induced by doxorubicin in synchronized P388 cells. Mol Phamacol 1996;49:832-41.
19. Litwiniec A, Grzanka A, Helmin-Basa A, Gackowska L, Grzanka D. Features of senescence and cell death induced by doxorubicin in A549 cells: organization and level of selected cytoskeletal proteins. J Cancer Res Clin Oncol 2010;136:717-36.
20. Nigg EA. Mitotic kinases as regulators of cell division and its checkpoints. Nature Rev Mol Cell Biol 2001;2:21-32.
21. Park SS, Eom YW, Choi KS. Cdc2 and Cdk2 play critical roles in low dose doxorubicin-induced cell death through mitotic catastrophe but not in high dose doxorubicin-induced apoptosis. Biochem Biophys Res Commun 2005;334:1014-21.
22. Pines J, Hunter T. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 1990;346:760-3.
23. Pontano LL, Diehl JA. Speeding through cell cycle roadblocks: nuclear cyclin D1-dependent kinase and neoplastic transformation. Cell Div 2008;3:12.
24. Porter LA, Cukier IH, Lee JM. Nuclear localization of cyclin B1 regulates DNA damage-induced apoptosis. Blood 2003;101:1928-33.
25. Schneider U, Schwenk H, Bornkamm G. Characterization of EBVgenome negative 'null' and 'T' cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non- Hodgkin lymphoma. Int J Cancer 1977;19:621-26.
26. Siddiqui RA, Jenski LJ, Harvey KA, Wiesehan JD, Stillwell W, Zaloga GP. Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochem J 2003;371:621-9.
27. Somerville L, Cory JG. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells. Anticancer Res 2000;20:3347-55.
28. Sugrue MM, Shin DY, Lee SW, Aaronson SA. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci USA 1997;94:9648-53.
29. Terrano DT, Upreti M, Chambers TC. Cyclin-dependent kinase 1- mediated Bcl-XL/Bcl-2 phosphorylation acts as a functional link coupling mitotic arrest and apoptosis. Mol Cell Biol 2010;30:640-56.
30. Tiemann K, Alluin JV, Honegger A, Chomchan P, Gaur S, Yun Y et al. Small interfering RNAs targeting cyclin D1 and cyclin D2 enhance the cytotoxicity of chemotherapeutic agents in mantle cell lymphoma cell lines. Leuk Lymphoma 2011;52:2148-54.
31. Turinetto V, Porcedda P, Orlando O, De Marchi M, Amoroso A, Giachino C. The cyclin-dependent kinase inhibitor 5,6-dichloro-1-beta-Dribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status. BMC Cancer 2009;9:281.
32. Villamarin S, Ferrer-Miralles N, Mansilla S, Priebe W, Portugal J. Induction of G(2)/M arrest and inhibition of c-myc and p53 transcription by WP631 in Jurkat T lymphocytes. Biochem Pharmacol 2002;63:51-8.
33. Wang X, Song Y, Ren J, Qu X. Knocking-down cyclin A(2) by siRNA suppresses apoptosis and switches differentiation pathways in K- 562 administration with doxorubicin. PLoS ONE 2009;4:e6665.
34. Wei M, Zhu L, Li Y, Chen W, Han B, Wang Z et al. Knocking down cyclin D1b inhibits breast cancer cell growth and suppresses tumor development in a breast cancer model. Cancer Sci USA 2011;102:1537-44.
35. Zhou BB, Li H, Yuan J, Kirschner MW. Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. Proc Natl Acad Sci USA 1998;95:6785-90.
36. Zuryn A, Grzanka A, Stepien A, Grzanka D, Debski R, Smolinski D. Expression of cyclin A in human leukemia cell line HL-60 following treatment with doxorubicin and etoposide: the potential involvement of cyclin A in apoptosis. Oncol Rep 2007;17:1013-9.